NCT05431413View on ClinicalTrials.gov

Rapid Improvement of Depression of Fluoxetine Combined With ATP

PHASE2RecruitingINTERVENTIONAL
Enrollment

195

Participants

Timeline

Start Date

January 7, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2025

Conditions
Depression
Interventions
DRUG

Control group: Fluoxetine and Placebo

Cap Fluoxetin 20mg OD for four weeks and injection 100ml normal saline(NS) BD for two weeks.

DRUG

Experimental group: Fluoxetine and ATP

Cap Fluoxetin 20mg OD for four weeks and injection ATP 100mg in NS BD for two weeks.

DRUG

Control group: Fluoxetine and Phosphocreatine

Cap Fluoxetin 20mg OD for four weeks and injection Phosphocreatine 1g in NS BD for two weeks.

Trial Locations (1)

510515

RECRUITING

Nanfang Hospital, Southern Medical University, Guangzhou

All Listed Sponsors
lead

Nanfang Hospital, Southern Medical University

OTHER